The combination treatment of angelicin and TRAIL was able to induce apoptosis in other cancer cell lines, such as Sk-hep1 and MDA-MB-361 cells but normal cell lines were not affected (Min et al., 2018). This evidence concerns the gene TNFSF10 and cancer.